Oseltamivir-resistant pandemic (H1N1)2009 in Yemen - case report [PDF]
Background During the influenza season of 2007-08, oseltamivir-resistant influenza A (H1N1) viruses emerged in several countries in Europe, North America, and Asia.
Al-Kohlani Abdulhakeem +3 more
doaj +4 more sources
Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia
Background The relationship between early oseltamivir treatment (within 48 h of symptom onset) and mortality in patients admitted to intensive care units (ICUs) with severe influenza is disputed.
Gerard Moreno +18 more
doaj +2 more sources
Occurrence and characterization of oseltamivir-resistant influenza virus in children between 2007-2008 and 2008-2009 seasons [PDF]
PurposeThere was a global increase in the prevalence of oseltamivir-resistant influenza viruses during the 2007-2008 influenza season. This study was conducted to investigate the occurrence and characteristics of oseltamivir-resistant influenza viruses ...
Seoung Geun Kim +17 more
doaj +3 more sources
Oseltamivir Resistance during Treatment of Influenza A (H5N1) Infection [PDF]
Influenza A (H5N1) virus with an amino acid substitution in neuraminidase conferring high-level resistance to oseltamivir was isolated from two of eight Vietnamese patients during oseltamivir treatment.
Tran Tan Thanh, Gavin J D Smith, Yi Guan
exaly +3 more sources
Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivir [PDF]
Ferrets are widely used to study human influenza virus infection. Their airway physiology and cell receptor distribution makes them ideal for the analysis of pathogenesis and virus transmission, and for testing the efficacy of anti-influenza ...
Barclay, Wendy S. +17 more
core +24 more sources
Evaluating the Health Economic Impacts of Baloxavir Marboxil and Oseltamivir for the Treatment of Influenza in Adult Outpatients in Hong Kong: A Cost-Effectiveness Analysis. [PDF]
ABSTRACT Background Baloxavir marboxil, an antiviral used only in private hospitals in Hong Kong since February 2019 for treating influenza, is recognized for its efficacy against strains resistant to standard antiviral agents, providing an alternative to neuraminidase inhibitors such as oseltamivir.
Chen R, Shao Z, Bi K, Cowling BJ, Du Z.
europepmc +2 more sources
Evaluation of Oseltamivir Used to Prevent Hospitalization in Outpatients With Influenza
Key Points Question Is the administration of oseltamivir to adult and adolescent outpatients with confirmed influenza associated with a reduced risk of first hospitalization?
R. Hanula +5 more
semanticscholar +1 more source
Annual and sporadic influenza outbreaks pose a great threat to human health and the economy worldwide. Moreover, the frequent mutation of influenza viruses caused by antigen drift complicates the application of antiviral therapeutics.
Zhichao Xu +11 more
semanticscholar +1 more source
Importance Oseltamivir is recommended for all children hospitalized with influenza, despite limited evidence supporting its use in the inpatient setting.
P. Walsh +5 more
semanticscholar +1 more source
Efficacy of oseltamivir in the treatment of patients infected with Covid-19
Objective The recent unprecedented pandemic caused by Sars-Cov-2 (the new coronavirus 2019), is threatening public health around the world. Although several studies have been performed, there is no identified treatment for Covid-19 patients.
Abolfazl Zendehdel +4 more
semanticscholar +1 more source

